Article

Review of Therapies for the Treatment of Oral Chronic Graft-Versus-Host Disease

Margaret Harvey Granitto

Jane M. Fall-Dickson

Colleen K. Norton

Colleen Sanders

oral chronic graft-versus-host disease, clinical trials, allogeneic hematopoietic stem cell transplantation
CJON 2014, 18(1), 76-81. DOI: 10.1188/14.CJON.76-81

Oral chronic graft-versus-host disease is a frequent complication of allogeneic hematopoietic stem cell transplantation, contributing to patient morbidity and mortality. Although an optimal treatment is not available, several systemic and topical or local therapies have shown efficacy in treating the disease. New therapies are being tested through clinical trials. This article examines the efficacy and safety of reported treatment modalities studied from 2006-2012. Nurses will encounter patients with oral chronic graft-versus-host disease suffering from pain, discomfort, and a decreased quality of life. Knowledge of new therapies found to be effective in managing these symptoms is imperative. Nurses play a key role in the assessment and management of this complex oral disease.

Members Only
Not a current ONS member or journal subscriber?

Purchase This Article

Receive a PDF to download and print.